Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma

Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma

<p>Abstract</p> <p>Background</p> <p>Synovial sarcoma is a high-grade malignant tumor of soft tissue, characterized by the specific chromosomal translocation t(X;18), and its resultant SYT-SSX fusion gene. Despite intensive multimodality therapy, the majority of metasta...

Full description

Bibliographic Details
Main Authors: Asanuma Hiroko, Shimozawa Kumiko, Ikeda Hideyuki, Sahara Hiroeki, Kimura Sigeharu, Tsukahara Tomohide, Nagoya Satoshi, Sato Yuriko, Ida Kazunori, Wada Takuro, Kawaguchi Satoshi, Torigoe Toshihiko, Hiraga Hiroaki, Ishii Takeshi, Tatezaki Shin-ichiro, Sato Noriyuki, Yamashita Toshihiko
Format: Article
Language:English
Published: BMC 2005-01-01
Series:Journal of Translational Medicine
Subjects:
Synovial sarcoma
SYT-SSX
antigenic peptide
vaccination
Phase I trial
Online Access:http://www.translational-medicine.com/content/3/1/1

Internet

http://www.translational-medicine.com/content/3/1/1

Similar Items